A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

NCT06564038 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukaemia
Small Lymphocytic Lymphoma
Mantle-cell Lymphoma
Large B-cell Lymphoma
B-cell Non-Hodgkin Lymphoma

Interventions

DRUG: Surovatamig
DRUG: Prednisone (or equivalent)
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Acalabrutinib

Sponsor

AstraZeneca